Legal News

California may be moving toward a new form of liability. The state Supreme Court declined to hear an appeal from Wyeth in a case the held the drug maker liable for injuries caused by generic versions of Reglan (metoclopramide) made by another manufacturer.

In an effort to permit community pharmacies to negotiate better contracts, Reps. Anthony Weiner (D-NY) and Jerry Moran (R-KS) recently introduced legislation designed to level the playing field between community pharmacies and pharmacy benefit managers (PBMs).

Drugstore.com continues to experience growth, particularly in sales of OTC products, and is expanding internationally, a company executive told attendees at the Jeffries 5th Annual Internet & Media Conference in New York this week.

Versions of the Pain Care Act have been introduced in Congress every year since 2003. Passed in the House of Representatives in 2008, it must pass there again before moving to the Senate.

Three pharmacy owners and four pharmacists were among 12 people recently indicted for participating in a conspiracy that dispensed and sold thousands of dosages of anabolic steroids ? including powerful veterinary steroids approved for animal use only ? to users throughout the United States.

The slumping U.S economy and government regulations will cause pharmacy sales to grow only around 1.3 percent rate in 2009, according to new research presented last week at the American Society for Automation in Pharmacy?s Industry and Technology Issues in St. Petersburg, Fla.

Boston has followed San Francisco's lead and has banned pharmacy tobacco sales. It went even further and banned cigarette sales on college campuses.

A former pharmacist has been convicted of felony conflict of interest charges for taking payments from drug companies and pocketing money for supervising pharmacy interns from Duquesne University.

The U.S. Food and Drug Administration recently recalled two unapproved and uncleared devices whose manufacturers claimed could treat various medical conditions. The recall was a Class 1, which means there is a reasonable probability that the use of a device will cause adverse reactions, including death.